Compounds > omega-n-methylarginine
Page last updated: 2024-09-03

omega-n-methylarginine and Breast Cancer

omega-n-methylarginine has been researched along with Breast Cancer in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guendisch, D; Kondratyuk, TP; Marler, L; Park, EJ; Pezzuto, JM; Shen, L; Sun, D; Wright, AD1
Fu, BM; Zeng, M; Zhang, L1
Broemeling, LD; Ekmekcioglu, S; Grimm, EA; Simeone, AM; Tari, AM1
Radisavljevic, Z2
Batten, JJ; Kakkar, AK; Mathie, RT; Sirivatanauksorn, Y; Thamrongwittawatpong, L; Williamson, RC1
Peer, NG; Ruers, TJ; te Boekhorst, DS; van der Sluis, RF; Wobbes, T1
Eberle, J; Fecker, LF; Geilen, CC; Orfanos, CE1

Other Studies

8 other study(ies) available for omega-n-methylarginine and Breast Cancer

ArticleYear
Design, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agents.
    Bioorganic & medicinal chemistry, 2011, Nov-01, Volume: 19, Issue:21

    Topics: Antineoplastic Agents; Aromatase; Breast Neoplasms; Carbolines; Cell Line, Tumor; Cell Proliferation; Female; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); NF-kappa B; Nitric Oxide; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Tumor Necrosis Factor-alpha

2011
Inhibition of endothelial nitric oxide synthase decreases breast cancer cell MDA-MB-231 adhesion to intact microvessels under physiological flows.
    American journal of physiology. Heart and circulatory physiology, 2016, 06-01, Volume: 310, Issue:11

    Topics: Animals; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Mesentery; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley

2016
A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.
    Molecular cancer therapeutics, 2002, Volume: 1, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Fenretinide; Flow Cytometry; Humans; Immunohistochemistry; Interferon-gamma; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Tamoxifen; Tumor Cells, Cultured

2002
Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3A)/ROCK kinase pathway in human breast carcinoma cells.
    Cancer, 2003, Mar-01, Volume: 97, Issue:5

    Topics: Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; DNA-Binding Proteins; Female; Forkhead Box Protein O1; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Intracellular Signaling Peptides and Proteins; Nitric Oxide; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; rho-Associated Kinases; Signal Transduction; Transcription Factors; Tumor Cells, Cultured

2003
Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells.
    Journal of cellular biochemistry, 2004, May-01, Volume: 92, Issue:1

    Topics: Arginine; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Female; Humans; Mitosis; Nitric Oxide; omega-N-Methylarginine; Phosphorylation; Retinoblastoma Protein; Serine; Tumor Suppressor Protein p53

2004
The effect of N(G)-monomethyl-L-arginine and tamoxifen on nitric oxide production in breast cancer cells stimulated by oestrogen and progesterone.
    The European journal of surgery = Acta chirurgica, 2001, Volume: 167, Issue:7

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Neovascularization, Pathologic; Nitric Oxide; omega-N-Methylarginine; Progesterone; Tamoxifen; Tumor Cells, Cultured

2001
Periodic follow-up after breast cancer and the effect on survival.
    The European journal of surgery = Acta chirurgica, 2001, Volume: 167, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Continuity of Patient Care; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Netherlands; Nitric Oxide; omega-N-Methylarginine; Retrospective Studies; Survival Analysis; Tamoxifen

2001
Inducible nitric oxide synthase is expressed in normal human melanocytes but not in melanoma cells in response to tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide.
    The Journal of investigative dermatology, 2002, Volume: 118, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Interferon-gamma; Lipopolysaccharides; Melanocytes; Melanoma; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2002